1. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics-2016 Update: A Report From the American Heart Association. Circulation (2016) 133:e38-360. doi: 10.1161/CIR.0000000000000350.
2. Kuhn EN, Wu SM. Origin of cardiac progenitor cells in the developing and postnatal heart. J Cell Physiol (2010) 225:321-5. doi: 10.1002/jcp.22281.
3. Patel VK, Mathison M, Singh VP, Yang J, Rosengart TK. Direct cardiac cellular reprogramming for cardiac regeneration. Curr Treat Options Cardiovasc Med (2016) 18:58. doi: 10.1007/s11936-016-0480-8.
4. Rizzino A. Concise review: the Sox2-Oct4 connection: critical players in a much larger interdependent network integrated at multiple levels. Stem Cells (2013) 31:1033-9. doi: 10.1002/stem.1352.
5. Später D, Hansson EM, Zangi L, Chien KR. How to make a cardiomyocyte. Development (2014) 141:4418-31. doi: 10.1242/dev.091538.
6. Zhang Y, Sivakumaran P, Newcomb AE, Hernandez D, Harris N, Khanabdali R, et al. Cardiac repair with a novel population of mesenchymal resident in the human heart, 2015. Stem Cells. (2015) 33:3100-13. doi: 10.1002/stem.2101.
7. Srivastava D, Ivey KN. Potential of stem-cell-based therapies for heart disease. Nature (2006) 441:1097-9. doi: 10.1038/nature04961.
8. Chen Y, Yang Z, Zhao ZA, Shen Z. Direct reprogramming of fibroblasts into Cardiomyocytes. Stem Cell Res Ther (2017) 8:118. doi: 10.1186/s13287-017-0569-3.
9. Ieda M, Fu JD, Delgado-Olguin P, Vedantham V, Hayashi Y, Bruneau BG, et al. Direct reprogramming of fibroblasts into functional Cardiomyocytes by defined factors. Cell (2010) 142: 375-86. doi: 10.1016/j.cell.2010.07.002.
10. Davis RP, Casini S, van den Berg CW, Hoekstra M, Remme CA, Dambrot C, et al. Cardiomyocytes derived from pluripotent stem cells recapitulate electrophysiological characteristics of an overlap syndrome of cardiac sodium channel disease. Circulation (2012) 125:3079-91. doi: 10.1161/CIRCULATIONAHA.111.066092.
11. Nelson TJ, Martinez-Fernandez A, Yamada S, Perez-Terzic C, Ikeda Y, Terzic A. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation (2009) 120:408-16. doi: 10.1161/CIRCULATIONAHA.109.865154.
12. Hosoda T. C-kit-positive cardiac stem cells and myocardial regeneration 2. Am J Cardiovasc Dis (2012) 2:58-67.
13. Bolli R, Chugh AR, D’Amario D, Loughran JH, Stoddard MF, Ikram S, et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (scipio): initial results of a randomised phase 1 trial. Lancet (2011) 378:1847-57. doi: 10.1016/S0140-6736(11)61590-0.
14. Davis RL, Weintraub H, Lassar AB. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell (1987) 51:987-1000. doi: 10.1016/0092-8674(87)90585-x.
15. Laugwitz K-L, Moretti A, Caron L, Nakano A, Chien KR. Islet1 cardiovascular progenitors: a single source for heart lineages? Development (2008) 135:193-205. doi: 10.1242/dev.001883.
16. Genead R, Danielsson C, Andersson AB, Corbascio M, Franco-Cereceda A, Sylvén C et al. Islet-1 cells are cardiac progenitors present during the entire lifespan: from the embryonic stage to adulthood. Stem Cells Dev (2010) 19:1601-15. doi: 10.1089/scd.2009.0483.
17. Fonoudi H, Yeganeh M, Fattahi F, Ghazizadeh Z, Rassouli H, Alikhani M, et al. ISL1 protein transduction promotes cardiomyocyte differentiation from human embryonic stem cells. PLOS ONE (2013) 8:e55577. doi: 10.1371/journal.pone.0055577.
18. Moretti A, Caron L, Nakano A, Lam JT, Bernshausen A, Chen Y, et al. Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell. (2006) 127:1151-65. doi: 10.1016/j.cell.2006.10.029.
19. Bu L, Jiang X, Martin-Puig S, Caron L, Zhu S, Shao Y, et al. Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature (2009) 460:113-7. doi: 10.1038/nature08191.
20. Wagner N, Wagner KD. Every beat you take-the Wilms’ tumor suppressor WT1 and the heart. Int J Mol Sci (2021) 22:7675. doi: 10.3390/ijms22147675. 21 Sjoerd N. Duim, Marie-José Goumans, and Boudewijn P. T. Kruithof2016; Chapter 13. Wilmtumor [internet]. Brisbane (AU): Codon Publications. In: Cardiac Development and Disease van den Heuvel-Eibrink MM, editor. doi:\ 10.15586/codon.wt.2016.ch13
22. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, et al. WT-1 is required for early kidney development. Cell (1993) 74:679-91. doi: 10.1016/0092-8674(93)90515-r.
23. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell (2003) 114:763-76. doi: 10.1016/s0092-8674(03)00687-1.
23. Männer J, Wessel A, Yelbuz TM. How does the tubular embryonic heart work? Looking for the physical mechanism generating unidirectional blood flow in the valveless embryonic heart tube. Dev Dyn (2010) 239:1035-46. In the developing heart.
24. Laflamme MA, Murry CE. Heart regeneration. Nature (2011) 473:326-35. doi: 10.1038/nature10147.
25.Addis RC, Ifkovits JL, Pinto F, Kellam LD, Esteso P, Rentschler S, et al. Optimization of direct fibroblast reprogramming to Cardiomyocytes using calcium activity as a functional measure of success. J Mol Cell Cardiol (2013) 60:97-106.
26. Srivastava D, Ieda M. Critical factors for cardiac reprogramming. Circ Res (2012) 111:5-8. doi: 10.1161/CIRCRESAHA.112.271452.
27. Xin M, Olson EN, Bassel‐Duby R. Mending broken hearts: cardiac development as a basis for adult heart regeneration and repair. Nat Rev Mol Cell Biol (2013) 14:529-41. doi: 10.1038/nrm3619.
28. Välimäki MJ, Ruskoaho HJ. Targeting GATA4 for cardiac repair. IUBMB Life (2020) 72:68-79. doi: 10.1002/iub.2150.
29. Lyons I, Parsons LM, Hartley L, Li R, Andrews JE, Robb L, et al. Myogenic and morphogenetic defects in the heart tubes of murine embryos lacking the homeo box gene Nkx2-5. Genes Dev. (1995) 9:1654-66. doi: 10.1101/gad.9.13.1654.
30. Tanaka M, Kasahara H, Bartunkova S, Schinke M, Komuro I, Inagaki H, et al. Vertebrate homologs of tinman and bagpipe: roles of the homeobox genes in cardiovascular development. Dev Genet (1998) 22:239-49. doi: 10.1002/(SICI)1520-6408(1998)22:3<239::AID-DVG6>3.0.CO;2-7.
31. Kasahara H, Bartunkova S, Schinke M, Tanaka M, Izumo S. Cardiac and extra cardiac expression of Csx/Nkx2.5 homeodomain protein. Circ Res (1998) 82:936-46. doi: 10.1161/01.res.82.9.936.
32. Pashmforoush M, Lu JT, Chen H, Amand TS, Kondo R, Pradervand S, et al. Nkx2-5 pathways and congenital heart disease; loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block. Cell (2004) 117:373-86. doi: 10.1016/s0092-8674(04)00405-2.
33. Abdul Samad F, Suliman BA, Basha SH, Manivasagam T, Essa MM. A comprehensive in silico analysis on the structural and functional impact of SNPs in the congenital heart defects associated with NKX2-5 gene-A molecular dynamic simulation approach. PLoS One (2016) 11:e0153999. doi: 10.1371/journal.pone.0153999.
34. Cao N, Huang Y, Zheng J, Spencer CI, Zhang Y, Fu JD, et al. Conversion of human fibroblasts into functional Cardiomyocytes by small molecules. Science (2016) 352:1216-20. doi: 10.1126/science.aaf1502.
35. Steinhauser ML, Lee RT. Regeneration of the heart. EMBO Mol Med (2011) 3:701-12. doi: 10.1002/emmm.201100175.
36 Weinberger F, Eschenhagen T. Cardiac regeneration: New Hope for an old dream. Annu Rev Physiol (2021) 83:59-81. doi: 10.1146/annurev-physiol-031120-103629.
37 Raghavan PR. Policosanol nanoparticles, US patent 8,722,093, US patent 9,034,383. May 2014; Policosanol Nanoparticles;B2:B2 (May 2015); Metadichol Liquid and Gel Nanoparticle formulations US patent 9,006,292 B2.
38. Alemán CL, Más R, Hernández C, Rodeiro I, Cerejido E, Noa M, et al. A 12-month study of policosanol oral toxicity in Sprague Dawley rats. Toxicol Lett (1994) 70(1):77-87. doi: 10.1016/0378-4274(94)90147-3.
39. Alemán CL, Ferreiro RM, Puig MN, Guerra IR, Ortega CH, Capote A. Carcinogenicity of policosanol in Sprague Dawley rats: a 24 month study. Teratog Carcinog Mutagen (1994) 14:239-49. doi: 10.1002/tcm.1770140505.
40. Alemán CL, Puig MN, Elías EC, Ortega CH, Guerra IR, Ferreiro RM, et al. Carcinogenicity of policosanol in mice: an 18-month study. Food Chem Toxicol (1995) 33:573-8. doi: 10.1016/0278-6915(95)00026-x.
41. Nikitin A, Egorov S, Daraselia N, Mazo I. Pathway studio--the analysis and navigation of molecular networks. Bioinformatics (2003) 19:2155-7. doi: 10.1093/bioinformatics/btg290.
42. Sivachenko AY, Yuryev A, Daraselia N, Mazo I. J Bioinform Comput Biol (2007) 5:429-56.
43 Miyamoto Y, Taniguchi H, Hamel F, Silversides DW, Viger RS. A GATA4/WT1 cooperation regulates transcription of genes required for mammalian sex determination and differentiation. BMC Mol Biol. 2008 Apr 29;9:44. doi: 10.1186/1471-2199-9-44.
44. Miyamoto Y, Taniguchi H, Hamel F, Silversides DW, Viger RS, GATA A. A GATA4/WT1 cooperation regulates transcription of genes required for mammalian sex determination and differentiation. BMC Mol Biol (2008) 9:44. doi: 10.1186/1471-2199-9-44.
45. Dorn T, Goedel A, Lam JT, Haas J, Tian Q, Herrmann F, et al. Direct Nkx2-5 transcriptional repression of Isl1 controls cardiomyocyte subtype identity. Stem Cells (2015) 33:1113-29. doi: 10.1002/stem.1923.
46 Wagner K-D, Cherfils-Vicini J, Hosen N, Hohenstein P, Gilson E, Hastie ND, et al. The Wilms’ tumor suppressor, Wt1 is a major regulator of tumor angiogenesis and progression. Nat Commun (2014) 5:5852. doi: 10.1038/ncomms6852.
47. Tomczak A, Mortensen JM, Winnenburg R, Liu C, Alessi DT, Swamy V, et al. Interpretation of biological experiments changes with evolution of the Gene Ontology and its annotations. Sci Rep (2018) 8:5115. doi: 10.1038/s41598-018-23395-2.
48. Raghavan PR. Systolic and diastolic BP control in metabolic syndrome patients with Metadichol® a novel nano emulsion lipid. J Cardiol & Cardiovasc Ther 2017; 5(2): 555660. doi: 10.19080/JOCCT.2017.05.555660.
49. Gallo G, Volpe M, Savoia C. Endothelial dysfunction in hypertension: current concepts and clinical implications. Front. Med (2022) 8:798958. doi: 10.3389/fmed.2021.798958.